This compound is a pyrazole derivative featuring a boronic ester group. It is primarily utilized as a pharmaceutical intermediate in the synthesis of active pharmaceutical ingredients.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1282518-60-8
4,4-DIFLUORO-6-AZASPIRO[2.5]OCTANE HYDROCHLORIDE
Pharmaceutical intermediate
4-Methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazole monohydrate
Pharmaceutical intermediate for telmisartan
Methyl 6-(4-methoxyphenyl)-2-naphthoate
pharmaceutical intermediate
(S)-2-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)propan-1-ol
Vitamin D analog intermediate
1-methyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
Pharmaceutical intermediate for synthesis
3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
Research reagent for organic synthesis
5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrazole
research compound
1-propan-2-yl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole
ZKZJXVGTTZXHGX-UHFFFAOYSA-N
B1(OC(C(O1)(C)C)(C)C)C2=CC=NN2C(C)C
—